✦ LIBER ✦

6049 Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer

✍ Scribed by Hatanaka, K.; Komatsu, Y.; Yuki, S.; Nakamura, M.; Miyagishima, T.; Kudo, M.; Munakata, M.; Sakata, Y.; Asaka, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of combined chemotherapy

✍ Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 104 KB

Phase I study of bevacizumab combined wi

✍ Hitoshi Kusaba, Taito Esaki, Junji Kishimoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 179 KB

A phase II study of capecitabine, irinot

✍ Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jenni 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

Bevacizumab in Combination With Chemothe

✍ Howard S. Hochster 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Phase II study of oral S-1 with irinotec

✍ Yasuhide Yamada, Tatsuro Yamaguchi, Hiroshi Matsumoto, Yasushi Ichikawa, Ayumu G 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 160 KB

Phase II trial of combined irinotecan an

✍ Paulo M. Hoff; Robert A. Wolff; Henry Xiong; Dennie Jones; Edward Lin; Cathy Eng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB